DNAJA1 Antibody [J3K12]

N.º de catálogo F4809

Imprimir

Descripción biológica

Especificidad DNAJA1 Antibody [J3K12] detecta niveles endógenos de la proteína DNAJA1 total.
Antecedentes DNAJA1 (DnaJ homolog subfamily A member 1) es una co-chaperona Hsp40 de tipo I citosólica esencial para la proteostasis y la señalización del estrés. Presenta un dominio J N-terminal (residuos 4–70, con un motivo HPD en His33-Pro34-Asp35 crucial para la estimulación de la ATPasa Hsp70), un dominio de dedo de zinc C4 (aa 78–115, que contiene ocho cisteínas que coordinan dos iones Zn²⁺ para sondear parches hidrofóbicos en proteínas cliente), un enlazador flexible rico en glicina/fenilalanina (aa 116–165) y un dominio C-terminal de unión a sustrato (aa 166–397) que comprende láminas β y hélices α apiladas, además de un motivo CTIL355–358 farnesilado para la unión dinámica al RE o a la membrana plasmática. En el ciclo de la chaperona Hsp70, la hélice α II del dominio J se acopla al dominio de unión de nucleótidos de Hsp70, acelerando la hidrólisis de ATP más de 1000 veces y atrapando los sustratos en el estado unido a ADP. Los dedos de zinc entregan clientes como la p53 mutante conformacional (donde DNAJA1 se une al dominio central de mutp53 para bloquear estéricamente la ubiquitinación CHIP E3 en Lys620, estabilizando conformaciones oncogénicas que impulsan la invasión del cáncer de páncreas y colangiocarcinoma a través de filopodios mediados por Cdc42/Rac1), CFTR ΔF508 (dirigiendo la clasificación para la retención en el RE y la retrotranslocación a través de Hsc70), las fibrillas de tau (facilitando la desagregación independiente de Hsp104) y los complejos de importación nuclear de la influenza PB2/PA. DNAJA1 también restringe la hiperactivación de JNK/c-Jun bajo estrés oxidativo y del RE al promover la secuestración de SAPK mediada por Hsc70, previniendo así la permeabilización de la membrana externa mitocondrial mediada por BAX y la apoptosis. Además, modula la agregación de polyQ-htt en modelos de Huntington y el tráfico del canal hERG. La regulación a la baja de DNAJA1 en tumores de PDAC aumenta paradójicamente la persistencia de mutp53 y el crecimiento tumoral, sensibilizando estos tumores a los inhibidores del dominio J (como A11, que se dirige a Y7/K44/Q47 para interrumpir la interacción de mutp53 y promover su eliminación proteasomal).

Información de uso

Aplicación WB, FCM Dilución
WB FCM
1:10000 - 1:50000 1:10 - 1:100
Reactividad Human
Fuente Rabbit Monoclonal Antibody MW 45 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/24512202/
  • https://pubmed.ncbi.nlm.nih.gov/33229560/

Datos de aplicación

WB

Validado por Selleck

  • F4809-wb
    Lane 1: HepG2, Lane 2: SK-BR-3, Lane 3: Jurkat, Lane 4: Raji